What is the recommended treatment for a group B streptococcus (GBS) urine culture?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Group B Streptococcus Urinary Tract Infection

Penicillin G or ampicillin are the first-line treatments for Group B Streptococcus (GBS) urinary tract infections due to their narrow spectrum of activity and proven effectiveness against GBS. 1

Treatment Recommendations for Non-Pregnant Adults

First-Line Treatment Options:

  • Penicillin G: 5 million units IV initial dose, then 2.5-3.0 million units IV every 4 hours until clinical improvement 1
  • Ampicillin: 2 g IV initial dose, then 1 g IV every 4 hours until clinical improvement 1

Alternative Options (for penicillin-allergic patients):

  • Cefazolin: 2 g IV initial dose, then 1 g IV every 8 hours 1
  • Clindamycin: 900 mg IV every 8 hours (only if susceptibility testing confirms sensitivity) 1
  • Vancomycin: 1 g IV every 12 hours (for clindamycin-resistant strains) 1
  • Nitrofurantoin: For uncomplicated lower UTIs caused by GBS 2

Important Considerations

Susceptibility Testing

  • Susceptibility testing is essential for penicillin-allergic patients due to increasing resistance to alternative antibiotics 1
  • Recent studies have shown concerning resistance patterns:
    • 18.3% resistance to penicillin and 81.6% to ampicillin in some regions 3
    • 23.3% resistance to clindamycin and 30% to vancomycin 3
    • 31% resistance to azithromycin and ceftriaxone 2

Treatment Duration

  • Uncomplicated UTIs: 7-10 days
  • Complicated UTIs or pyelonephritis: 10-14 days
  • Continue treatment for at least 48-72 hours after the patient becomes asymptomatic 1

Special Considerations for Pregnant Women

Pregnant women with GBS bacteriuria require special management:

  1. Treatment of Current Infection:

    • Treat any GBS bacteriuria during pregnancy regardless of colony count 4, 5
    • GBS in urine at any concentration (even <100,000 CFU/mL) indicates heavy colonization 4
  2. Intrapartum Prophylaxis:

    • Women with GBS bacteriuria during pregnancy should receive intrapartum antibiotic prophylaxis during labor to prevent early-onset neonatal GBS disease 4, 5
    • No need for repeat GBS screening at 35-37 weeks if GBS bacteriuria was documented during the current pregnancy 5
  3. Prophylaxis Regimen During Labor:

    • Penicillin G: 5 million units IV initially, then 2.5 million units IV every 4 hours until delivery 4
    • Ampicillin: 2 g IV initially, then 1 g IV every 4 hours until delivery (acceptable alternative) 4
    • For penicillin-allergic women: clindamycin or erythromycin (if susceptible) 4

Clinical Pitfalls to Avoid

  1. Failing to distinguish between treatment and prophylaxis: Treatment of GBS UTI during pregnancy is separate from intrapartum prophylaxis to prevent neonatal GBS disease 1

  2. Not performing susceptibility testing in penicillin-allergic patients: With increasing resistance to alternative antibiotics, susceptibility testing is crucial 1, 3

  3. Overlooking GBS bacteriuria at any colony count during pregnancy: Any level of GBS in urine during pregnancy indicates heavy colonization and requires both treatment and intrapartum prophylaxis 4, 5

  4. Re-screening pregnant women with documented GBS bacteriuria: Women with GBS bacteriuria during pregnancy should not be re-screened at 35-37 weeks as they are presumed to be GBS colonized 5

  5. Using inappropriate antibiotics: Avoid erythromycin due to increasing resistance, and fluoroquinolones when alternatives exist 1

References

Guideline

Group B Streptococcus Urinary Tract Infections Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antibiotic resistance patterns of group B streptococcal clinical isolates.

Infectious diseases in obstetrics and gynecology, 2004

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of group B streptococcal bacteriuria in pregnancy.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.